During the past decade, Gastromedica SRL conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gastromedica SRL" are "Ulcerative Colitis" (4 trials), "Crohn's Disease" (3 trials), "HBV" (2 trials), "Chronic HBV Infection" (1 trials) and "Chronic HIV Infection" (1 trials). Many other conditions were trialed in "Gastromedica SRL" in a lesser frequency.

Most popular intervention types in "Gastromedica SRL" are "Drug" (9 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ontamalimab" (4 trials), "TAF" (2 trials), "TAF Placebo" (2 trials) and "TDF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gastromedica SRL" are 9 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gastromedica SRL". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Gastromedica SRL, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Gastromedica SRL, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".